[Chronic hepatitis C: patients with mild disease].
Quer JC, Diago M, Crespo J, García-Samaniego J, Morillas R, Andrade R, Ángel Simón M.
Gastroenterol Hepatol. 2014 Jul;37 Suppl 1:3-12. doi: 10.1016/S0210-5705(15)30002-9.
Chronic hepatitis C.
Sherlock DS.
Dis Mon. 1994 Mar;40(3):117-96.
Rationale for treating hepatitis C virus infection in patients with mild to moderate chronic kidney disease.
Ridruejo E, Mendizabal M, Silva MO.
Hemodial Int. 2018 Apr;22 Suppl 1:S97-S103. doi: 10.1111/hdi.12651.
Hepatitis C.
Liddle C.
Anaesth Intensive Care. 1996 Apr;24(2):180-3. doi: 10.1177/0310057X9602400209.
Treating histologically mild chronic hepatitis C: monotherapy, combination therapy, or tincture of time?
Levine RA.
Ann Intern Med. 1998 Aug 15;129(4):323-6. doi: 10.7326/0003-4819-129-4-199808150-00010.
Extrahepatic manifestations in chronic hepatitis C virus carriers.
Rosenthal E, Cacoub P.
Lupus. 2015 Apr;24(4-5):469-82. doi: 10.1177/0961203314556140.
Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C, Mauro E, Ermacora A, Doretto P, Fumagalli S, Tonizzo M, Toffolutti F, Gattei V.
Minerva Med. 2021 Apr;112(2):175-187. doi: 10.23736/S0026-4806.20.07120-7. Epub 2020 Nov 16.
Fitness-Dependent, Mild Mutagenic Activity of Sofosbuvir for Hepatitis C Virus.
Martínez-González B, Gallego I, Gregori J, Soria ME, Somovilla P, de Ávila AI, García-Crespo C, Durán-Pastor A, Briones C, Gómez J, Quer J, Domingo E, Perales C.
Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0039423. doi: 10.1128/aac.00394-23. Epub 2023 Jun 27.
Viral hepatitis C.
Czepiel J, Biesiada G, Mach T.
Pol Arch Med Wewn. 2008 Dec;118(12):734-40.
Mild hepatitis C: treat or monitor.
Main J, Thomas H.
J Viral Hepat. 2006 May;13(5):289. doi: 10.1111/j.1365-2893.2006.00765.x.
